Medicare Enrolled

Dr. Boris Ioffe, D.O.

Dermatology · Duncanville, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
706 W CENTER ST, Duncanville, TX 75116
9727800707
In practice since 2007 (18 years)
NPI: 1598949646 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ioffe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ioffe? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ioffe

Dr. Boris Ioffe is a dermatology in Duncanville, TX, with 18 years in practice. Based on federal Medicare data, Dr. Ioffe performed 6,594 Medicare services across 3,559 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ioffe received a total of $32,654 from 41 pharmaceutical and/or device companies across 1100 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ioffe is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 18% volume in TX$ $32,654 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,594
Medicare services
Top 18% in TX for dermatology
3,559
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~366 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Destruction of precancerous skin growths, 2-142,402$5$20
Office visit, established patient (20-29 min)1,416$59$267
Destruction of precancerous skin growth, 1853$36$199
Skin biopsy, tangential649$65$302
Destruction of skin growths (warts/lesions), 1-14341$77$338
Biopsy of related skin growth, each additional growth174$38$149
New patient office visit (30-44 min)156$68$331
Office visit, established patient (10-19 min)116$38$167
Office visit, established patient (30-39 min)112$90$378
Steroid injection (triamcinolone)90$1$20
Biopsy of ear52$53$286
New patient office or other outpatient visit, 15-29 minutes44$48$215
Destruction of precancer skin growth, 15 or more growths37$117$497
Drug injection, under skin or into muscle28$10$42
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm24$216$907
Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm20$100$509
Simple or single drainage of skin abscess18$87$372
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm18$124$532
New patient office visit (45-59 min)18$121$492
Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm14$69$433
Acne surgery12$89$348
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
15.1% medium
84.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$32,654
Total received (2018-2024)
Avg $4,665/year across 7 years
Top 9% in TX for dermatology
41
Companies
1,100
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$28,171 (86.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,783 (11.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$700 (2.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,310
2023
$4,183
2022
$4,761
2021
$3,572
2020
$2,773
2019
$4,809
2018
$8,245

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$4,996
Novartis Pharmaceuticals Corporation
$3,180
GENZYME CORPORATION
$2,361
AbbVie, Inc.
$2,159
Lilly USA, LLC
$1,911
ABBVIE INC.
$1,899
Sun Pharmaceutical Industries Inc.
$1,764
Regeneron Healthcare Solutions, Inc.
$1,371
Ortho Dermatologics, a division of Bausch Health US, LLC
$1,280
Amgen Inc.
$1,212
PFIZER INC.
$1,036
AbbVie Inc.
$1,016
UCB, Inc.
$1,015
Galderma Laboratories, L.P.
$866
E.R. Squibb & Sons, L.L.C.
$801
Celgene Corporation
$687
Biofrontera Inc.
$677
SUN PHARMACEUTICAL INDUSTRIES INC.
$623
LEO Pharma Inc.
$538
Incyte Corporation
$462
Dermavant Sciences, Inc.
$405
MAYNE PHARMA INC.
$334
Almirall LLC
$294
Genentech USA, Inc.
$273
Kyowa Kirin, Inc.
$227
Helsinn Therapeutics (U.S.), Inc.
$197
Arcutis Biotherapeutics, Inc.
$187
Boehringer Ingelheim Pharmaceuticals, Inc.
$187
VYNE Pharmaceuticals Inc.
$162
Mayne Pharma Inc.
$141
DUSA Pharmaceuticals, Inc.
$89
Journey Medical Corporation
$70
Mylan Institutional Inc.
$48
PruGen, Inc. Pharmaceuticals
$46
Verrica Pharmaceuticals Inc.
$24
Teva Pharmaceuticals USA, Inc.
$23
Mission Pharmacal Company
$21
Sandoz Inc.
$19
Mylan Pharmaceuticals Inc.
$18
Glenmark Therapeutics Inc.
$15
Pierre Fabre Pharmaceuticals, Inc.
$15
Top 3 companies account for 32.3% of total payments
Associated products mentioned in payments ›
20% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Ameluz · Avar · BLU-U · BRYHALI · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ELIDEL · ENSTILAR · EPIDUO FORTE · EUCRISA · Enbrel · Erivedge · FABRAZYME · HUMIRA · HYRIMOZ · Humira · ILUMYA · Ilumya · JUBLIA · JUBLIA EFINACONAZOLE · Klisyri · LEVULAN KERASTICK · LIBTAYO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · Mupirocin Cream · ODOMZO · OLUMIANT · OPZELURA · ORACEA · Odomzo · Otezla · POTELIGEO · Poteligeo · QBREXZA · REMICADE · RETIN-A-MICRO · RINVOQ · Rituxan · SILIQ · SIMLANDI · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Skyrizi · Sotyktu · TALTZ · TARGRETIN · TREMFYA · TargaDox · Tremfya · VALCHLOR · VTAMA · Winlevi · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for dermatology in TX.

Equivalent to $495 per 100 Medicare services performed
Looking for a dermatology in Duncanville?
Compare dermatologys in the Duncanville area by procedure volume, costs, and industry payment transparency.
Browse dermatologys nearby

Geographic Context

Dermatologys within 10 mi
159
Per 100K population
6.1
County median income
$74,149
Nearest hospital
METHODIST CHARLTON MEDICAL CENTER
2.3 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ioffe is a clinical cardiology specialist, with above-average Medicare volume (top 18% in TX), and high industry engagement (low-engagement, top 9%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ioffe experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Ioffe performed 2,402 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ioffe receive payments from pharmaceutical companies?
Yes. Dr. Ioffe received a total of $32,654 from 41 companies across 1,100 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ioffe's costs compare to other dermatologys in Duncanville?
Dr. Ioffe's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ioffe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →